Literature DB >> 18983548

Infectious endophthalmitis: clinical features, management and visual outcomes.

Jennifer C Fan1, Rachael L Niederer, Hirut von Lany, Philip J Polkinghorne.   

Abstract

AIM: To identify the clinical features and outcomes of infectious endophthalmitis in New Zealand.
METHODS: A retrospective review was performed on all patients presenting at Auckland Public Hospital with presumed infectious endophthalmitis between 1996 and 2004.
RESULTS: One hundred and six patients were diagnosed with infectious endophthalmitis over the 9-year study period. More than half the infections occurred in the perioperative setting (58.5%), with the next most common group being patients with a history of ocular trauma (18.9%). Endogenous endophthalmitis accounted for 16.0% of the cases while a small percentage arose from other causes. The mean interval between the onset of symptoms and presentation was 4.2 +/- 7.9 days. There was no significant difference in outcomes between clinical settings (P = 0.616) or between gram-positive, gram-negative and fungal infections (P = 0.090). Evisceration/enucleation was more likely in Pacific peoples and those with poor presenting visual acuity.
CONCLUSIONS: The most common clinical scenario for patients presenting with presumed infectious endophthalmitis in this series was in the perioperative setting. We did not find that the prognosis was influenced by the microbiological isolate or clinical setting. However, those patients presenting with poor acuities typically had the worst outcomes. Pacific ethnicity was also associated with increased rate of complications.

Entities:  

Mesh:

Year:  2008        PMID: 18983548     DOI: 10.1111/j.1442-9071.2008.01813.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  14 in total

1.  Severe bacterial endophthalmitis: towards improving clinical outcomes.

Authors:  Billy D Novosad; Michelle C Callegan
Journal:  Expert Rev Ophthalmol       Date:  2010-10

2.  Self-induced Elizabethkingia meningoseptica endophthalmitis: a case report.

Authors:  Paul P Connell; Sanj Wickremasinghe; Uma Devi; Mary Jo Waters; Penelope J Allen
Journal:  J Med Case Rep       Date:  2011-07-11

3.  Endogenous endophthalmitis: 10-year experience at a tertiary referral centre.

Authors:  P P Connell; E C O'Neill; D Fabinyi; F M A Islam; R Buttery; M McCombe; R W Essex; E Roufail; B Clark; D Chiu; W Campbell; P Allen
Journal:  Eye (Lond)       Date:  2010-10-22       Impact factor: 3.775

4.  A case of Pantoea endophthalmitis.

Authors:  Na Eun Lee; In Young Chung; Jong Moon Park
Journal:  Korean J Ophthalmol       Date:  2010-10-05

5.  Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes.

Authors:  Evelyn C O'Neill; Jonathan Yeoh; David C A Fabinyi; Dermot Cassidy; Rasik B Vajpayee; Penelope Allen; Paul P Connell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

6.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

Review 7.  Endophthalmitis: state of the art.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Krishna Kishor; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-01-08

8.  Causative Microorganisms of Infectious Endophthalmitis: A 5-Year Retrospective Study.

Authors:  Fang Duan; Kaili Wu; Jingyu Liao; Yongxin Zheng; Zhaohui Yuan; Junlian Tan; Xiaofeng Lin
Journal:  J Ophthalmol       Date:  2016-06-19       Impact factor: 1.909

9.  Bacterial endogenous endophthalmitis in Vietnam: a randomized controlled trial comparing vitrectomy with silicone oil versus vitrectomy alone.

Authors:  Tan Do; Do N Hon; Tin Aung; Nguyen Dtn Hien; Claude L Cowan
Journal:  Clin Ophthalmol       Date:  2014-08-28

10.  Clinical Features and Visual Acuity Outcomes in Culture-Positive Endogenous Fungal Endophthalmitis in Southern China.

Authors:  Fang Duan; Yao Yang; Zhaohui Yuan; Yongxin Zheng; Zhixing Cheng; Xiaofeng Lin
Journal:  J Ophthalmol       Date:  2017-08-13       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.